🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

Aspen Aerogels shares target lifted by Roth/MKM on PyroThin momentum

EditorEmilio Ghigini
Published 06/12/2024, 05:33 AM
ASPN
-

On Wednesday, Aspen Aerogels (NYSE:ASPN) stock received a boost as Roth/MKM raised its price target on the company's shares to $36.00 from the previous $28.00, while reaffirming a Buy rating. The firm's optimism is based on the expected continued success of Aspen's PyroThin product, which is anticipated to drive the company's growth.

The firm highlighted Aspen Aerogels' strategic focus on profitable growth and its positioning to capitalize on what it sees as a significant secular opportunity. With 2024 marked as a pivotal year, Aspen is expected to showcase positive net income and substantial growth in its thermal barrier business, which includes applications for electric vehicles.

The analyst pointed out that despite the broader electric vehicle market narrative, Aspen Aerogels is on track to demonstrate significant advancements. The company is projected to experience enhanced performance as it improves asset utilization and profitability continues to increase.

Aspen Aerogels specializes in the development and manufacture of high-performance aerogel insulation used in a variety of industrial and consumer applications. Its PyroThin products aim to provide thermal barriers that are critical for energy conservation and safety in industries such as automotive, building and construction, and energy production.

The new price target reflects a confidence in Aspen Aerogels' ability to outperform market expectations and deliver on its financial targets in the coming year. The firm's analysis suggests that investors may see value in the company's strategic initiatives and market positioning.

In other recent news, Aspen Aerogels has been the focus of several financial firms following strong first quarter results and robust guidance. TD Cowen increased Aspen Aerogels' stock price target to $36.00, maintaining a Buy rating, while Piper Sandler also lifted its price target from $30.00 to $36.00, keeping an Overweight rating. The adjustments reflect confidence in Aspen Aerogels' growth trajectory, particularly due to increased production from General Motors (NYSE:GM).

Furthermore, H.C. Wainwright raised its price target for Aspen Aerogels to $25, following the company's impressive Q1 performance and upward revision of its 2024 projections. The company now expects revenues of at least $380 million, up from the previous forecast of $350 million. The revised projections also include an increase in EBITDA to at least $55 million and EPS to at least $0.03.

Aspen Aerogels' Thermal Barrier capacity is expected to be fully allocated by late 2026, indicating strong market demand. The company is also considered a potential candidate for a Department of Energy loan, which could help restart operations at its Georgia manufacturing plant. These recent developments suggest a positive outlook for Aspen Aerogels, as it continues to navigate the expanding electric vehicle market.

InvestingPro Insights

Aspen Aerogels' journey towards profitability and growth is underscored by key metrics and analyst insights. According to InvestingPro data, the company has experienced a remarkable revenue growth of 53.37% over the last twelve months as of Q1 2024, with an even more impressive quarterly revenue growth of 107.3% in Q1 2024. This aligns with Roth/MKM's optimism regarding Aspen's financial targets and the success of its PyroThin product. Additionally, the strong return of 289.21% over the past year suggests robust investor confidence in Aspen's market performance and future potential.

InvestingPro Tips further reveal that analysts anticipate sales growth in the current year and predict that Aspen Aerogels will be profitable this year. These projections are crucial for investors considering the stock's high Price/Book multiple of 4.53. Moreover, with the company's liquid assets exceeding short-term obligations, Aspen appears to be in a solid position to manage its moderate level of debt and invest in growth opportunities.

For investors looking to delve deeper into Aspen Aerogels' financials and strategic positioning, InvestingPro offers additional insights and tips. Use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription, and access a total of 13 additional InvestingPro Tips that could help inform your investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.